Innovative Product Offering kegg’s unique fertility and pelvic floor health device, which is inserted vaginally and used daily, positions it as a pioneering solution in women’s health technology, opening avenues for partnerships with healthcare providers and wellness brands seeking advanced women's health solutions.

Growing Market Presence With support for over 80,000 women and a recent Series A funding of 6.5 million dollars, kegg is rapidly expanding its user base and market reach, indicating strong growth potential for distributors and healthcare organizations looking to target the fertility and women’s health segments.

Tech-Driven Data Insights Leveraging a robust tech stack including data analytics tools like Google Analytics and MySQL, kegg continuously gathers critical vaginal health data, providing sales opportunities within digital health platforms, research collaborations, and individualized wellness programs.

Revenue and Funding Stability Generating between 1 million and 10 million dollars in revenue with secured funding of 6.5 million dollars, kegg demonstrates financial stability and investment readiness, making it an attractive partner for collaborative sales efforts and strategic growth initiatives.

Market Differentiation As the only solution on the market designed for daily vaginal insertion to track fertility-related data, kegg offers a distinctive value proposition, making it a compelling product for healthcare providers, fertility clinics, and telehealth services aiming to enhance women’s reproductive health offerings.